Antithymocyte globulin preparations after heart transplantation: Cytokine responses in vivo and in vitro

S. C D Grant, W. R. Lamb, N. Yonan, I. V. Hutchinson, P. E C Brenchley

    Research output: Contribution to journalArticlepeer-review

    Abstract

    It is accepted that antithymocyte globulin (ATG) preparations vary in their bioactivity and side effects. However, this is poorly documented in the literature. We compared the clinical course and cytokine response of heart transplant patients who had received either Merieux or Stanford ATG preparations. The serum cytokine response (interleukin [IL]-6, tumor necrosis factor [TNF]-α, IL-4, and IL-10) of 28 consecutive heart transplant recipients was measured for 14 days after surgery using ELISAs. The effect of various ATG preparations on cytokine stimulation of whole blood in vitro was also evaluated. There was a much greater in vivo IL-6 and TNF-α response to Merieux than to Stanford ATG (P
    Original languageEnglish
    Pages (from-to)684-689
    Number of pages5
    JournalTransplantation
    Volume60
    Issue number7
    Publication statusPublished - 1995

    Keywords

    • Adolescent
    • Adult
    • therapeutic use: Antilymphocyte Serum
    • Chemistry, Pharmaceutical
    • blood: Cytokines
    • Female
    • prevention & control: Graft Rejection
    • immunology: Heart Transplantation
    • Humans
    • drug therapy: Infection
    • Male
    • Middle Aged

    Fingerprint

    Dive into the research topics of 'Antithymocyte globulin preparations after heart transplantation: Cytokine responses in vivo and in vitro'. Together they form a unique fingerprint.

    Cite this